Treatment satisfaction in patients with rrms treated with teriflunomide in routine clinical practice...
Treatment satisfaction in patients with rrms treated with teriflunomide in routine clinical practice: aubpro study design
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
More information
Scope and Contents
Contents
ObjectivesTeriflunomide is a once-daily immunomodulator approved for the treatment of patients with relapsing-remitting MS (RRMS). Here, we describe the design of AubPRO, a prospective observational study to evaluate treatment satisfaction using patient-reported outcomes (PROs) in patients with RRMS treated with teriflunomide (AUBAGIO) in routine c...
Alternative Titles
Full title
Treatment satisfaction in patients with rrms treated with teriflunomide in routine clinical practice: aubpro study design
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1896218359
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1896218359
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2017-316074.47
